{"Acute lymphocytic leukaemia": 93.27382365872154, "Acute lymphocytic leukaemia recurrent": 595.8548514827819, "B precursor type acute leukaemia": 776.1144927464509, "Bone marrow failure": 20.26168879248283, "Central nervous system leukaemia": 669.3600734530287, "Clostridium difficile colitis": 24.28982063661031, "Constipation": 2.07882795585028, "Cytokine release syndrome": 70.70118927729445, "Cytomegalovirus infection": 20.6074411769849, "Eating disorder": 15.19177570764113, "Febrile neutropenia": 10.8561907412344, "Gastrointestinal erosion": 549.966731309946, "Gastrointestinal haemorrhage": 2.7820656683259557, "Haematemesis": 9.98531170035907, "Infection": 3.0408832221837487, "Liver disorder": 4.078308777820453, "Lymphocyte count decreased": 48.75910590826577, "Melaena": 9.929797071466137, "Mucormycosis": 123.32032564269905, "Myelosuppression": 4.683653799613817, "Neoplasm progression": 5.854621454597867, "Neutrophil count decreased": 9.51351592707919, "Pancytopenia": 5.55301388025667, "Platelet count decreased": 5.596612474194603, "Pleural effusion": 4.257789297340652, "Pneumocystis jirovecii pneumonia": 36.114422173161934, "Red blood cell count decreased": 12.054738877525292, "Sepsis": 9.684008856701356, "Staphylococcal infection": 15.104143227457088, "Therapeutic product effect decreased": 4.227545948602611, "Tumour lysis syndrome": 42.451017519193314, "Visual impairment": 2.485637782188793}